Thompson TC - Search Results

1

SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.

Geng C, Zhang MC, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D, Robinson BD, Loda M, Barbieri CE, Yap TA, Corn PG, Hanash S, Broom BM, Pilié PG, Thompson TC. Geng C, et al. Among authors: thompson tc. Clin Cancer Res. 2023 Nov 1;29(21):4464-4478. doi: 10.1158/1078-0432.CCR-23-1439. Clin Cancer Res. 2023. PMID: 37581614 Free PMC article.

2

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Thompson TC, et al. Cancer Surv. 1991;11:55-71. Cancer Surv. 1991. PMID: 1726789

3

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Among authors: thompson tc. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

4

Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.

Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC. Slawin K, et al. Among authors: thompson tc. Cancer Res. 1993 Oct 1;53(19):4461-5. Cancer Res. 1993. PMID: 8402613

5

Transgenic models for the study of prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. Cancer. 1993 Feb 1;71(3 Suppl):1165-71. doi: 10.1002/1097-0142(19930201)71:3+<1165::aid-cncr2820711440>3.0.co;2-u. Cancer. 1993. PMID: 8428340 Review.

6

Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.

Timme TL, Yang G, Truong LD, Kadmon D, Park SH, Thompson TC. Timme TL, et al. Among authors: thompson tc. World J Urol. 1995;13(6):324-8. doi: 10.1007/BF00191212. World J Urol. 1995. PMID: 9116750

7

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes.

Yang G, Timme TL, Park SH, Thompson TC. Yang G, et al. Among authors: thompson tc. Prostate. 1997 Nov 1;33(3):151-6. doi: 10.1002/(sici)1097-0045(19971101)33:3<151::aid-pros1>3.0.co;2-m. Prostate. 1997. PMID: 9365541

8

Elevated expression of caveolin is associated with prostate and breast cancer.

Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC. Yang G, et al. Among authors: thompson tc. Clin Cancer Res. 1998 Aug;4(8):1873-80. Clin Cancer Res. 1998. PMID: 9717814

9

Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.

Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J, Thompson TC. Nasu Y, et al. Among authors: thompson tc. Nat Med. 1998 Sep;4(9):1062-4. doi: 10.1038/2048. Nat Med. 1998. PMID: 9734401

10

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.

Stapleton AM, Timme TL, Gousse AE, Li QF, Tobon AA, Kattan MW, Slawin KM, Wheeler TM, Scardino PT, Thompson TC. Stapleton AM, et al. Among authors: thompson tc. Clin Cancer Res. 1997 Aug;3(8):1389-97. Clin Cancer Res. 1997. PMID: 9815823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page